Upper gastrointestinal complications: the causes, consequences, and clinical outcomes.
Studies reveal that cyclooxygenase (COX-2) inhibitors seem to markedly lessen the risk of ulcers and upper gastrointestinal complications. Discussion, however, continues whether COX-2 inhibitors reduce the risk of clinical events to the same degree as nonsteroidal anti-inflammatory drugs.